Tiny $50M BLGO Just Got Smoked on 0.07% Volume – While Partnering With Billion‑Dollar Giants and Owning Half of a $100M Medical Sub
Yesterday’s **“flash sale”** in $BLGO wasn’t about bad news or a broken thesis – it was about structure and liquidity. A single seller moved roughly 500k shares (around $70k in value, only \~0.17% of the float), but because the stock is thinly traded, that was enough to knock the price down about 18% in a straight line. That drop then triggered stop‑loss orders and spooked short‑term traders, so more selling followed and, on paper, nearly **$10M in market cap evaporated** in a couple of hours even though nothing fundamental about the business changed.
That “500k dump” was roughly **$70,000 and only \~0.14% of the outstanding shares**, yet it triggered an \~18% price drop and wiped almost **$10M off the market cap** on paper. Stop losses tripped, weak hands got shaken, and about 1.6M shares moved from nervous holders into **stronger hands** who actually understand what’s being built here.
A bunch of us said in the **0.30s** that we wished for “just one more shot in the teens.” Well, be careful what you wish for – this is exactly that scenario.
Step back and look at the absurdity of the current setup:
• We’ve got a tiny company with a **$40–50M market cap** teaming up, across multiple subsidiaries, with partners that do **billions in revenue.** That’s a massive validation stamp on the tech and the team.
• The real reason we’re priced down here isn’t fundamentals; it’s that BioLargo historically hasn’t been great at **selling and scaling the products themselves**. The pattern is clear: when they pair **best‑in‑class tech** with strong commercial partners, it works.
• Look at **CupriDyne Clean** \- the odor tech is ridiculous. Anyone who has used it knows it does exactly what it says. With the right branding and channel partner, that turned into **Pooph**, a genuine blockbuster. That relationship blew up, but it proved the tech and the market.
• Now they’re plugging the gaps the right way:
• A **global water company (Aquatech)** to help scale the BEST PFAS/AEC solution and actually bid on **$100M‑plus projects.**
• In medical, a true gorilla that sees so much value in the **Clyrasept / BioClynse platform** that they insisted on a fully built and proven line capable of **2×1M units/year** before committing. That’s a serious vote of confidence, not a science‑project LOI.
• Clyra Medical on its own is already being valued around **$100M**, and BioLargo still owns roughly half of that. That’s before you ascribe any non‑zero value to BEST, Cellinity, BLEST, or ONM.
You don’t need to be a rocket scientist to see what’s going on here: the **disconnect is emotional, not fundamental**. Years of waiting, shifting timelines, and communication missteps have people selling into fear at exactly the time the platform is the most de‑risked it has ever been.
Personally, I’m buying as much as I can comfortably tuck away and hold. I like these odds a lot more with:
• A global PFAS partner
• A Big Kahuna lining up for launch
• A medical sub already worth 2× the BLGO market cap
while the market is panic‑selling 0.07% volume like it’s the end of the world.
https://preview.redd.it/ptwgv8e9sp0h1.jpg?width=850&format=pjpg&auto=webp&s=6e969c2b87a0a3fdb2098220d02105d351e5e23c
To learn more about BLGO - You Can find a detailed DD here. An update is in the works including the 3 great PRs we have had the past week.
[**🔥 I Own 1.25% of $BLGO - A Sub‑$50M Cleantech Company the Market Has Completely Mispriced**](https://www.reddit.com/r/pennystocks/comments/1sud7hi/i_own_125_of_blgo_a_sub50m_cleantech_company_the/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button)